| David S Cameron, MD | |
|
17 Wells St, Ste. 201, Westerly, RI 02891-2923 | |
| (401) 596-2033 | |
| (401) 596-9294 |
| Full Name | David S Cameron |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 25 Years |
| Location | 17 Wells St, Westerly, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801987615 | NPI | - | NPPES |
| 9003505 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD11350 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westerly Hospital | Westerly, RI | Hospital |
| Lawrence & Memorial Hospital | New london, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent Associates Of Westerly, Ltd. | 4284700766 | 2 |
News Archive
Virginia Commonwealth University researchers are testing a vaccine against opioid abuse developed by the Scripps Research Institute in California. The vaccine is meant to block the effects of heroin and fentanyl in patients with opioid use disorder.
Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary artery bypass grafting.
The International Committee of Medical Journal Editors (ICMJE) issued a statement today that the 11 member journals will require, as a condition of consideration for publication, registration in a public trials registry for clinical studies involving human patients.
Previous investigations have fallen short of proving cause-effect due to the complexity of human genetics and varying lifestyles. But the EU-funded GABRIEL study has pooled the very best in the field from all over Europe and can draw on the latest genomic and environmental data and approaches.
› Verified 2 days ago
| Entity Name | Ent Associates Of Westerly, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093806705 PECOS PAC ID: 4284700766 Enrollment ID: O20080908000022 |
News Archive
Virginia Commonwealth University researchers are testing a vaccine against opioid abuse developed by the Scripps Research Institute in California. The vaccine is meant to block the effects of heroin and fentanyl in patients with opioid use disorder.
Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary artery bypass grafting.
The International Committee of Medical Journal Editors (ICMJE) issued a statement today that the 11 member journals will require, as a condition of consideration for publication, registration in a public trials registry for clinical studies involving human patients.
Previous investigations have fallen short of proving cause-effect due to the complexity of human genetics and varying lifestyles. But the EU-funded GABRIEL study has pooled the very best in the field from all over Europe and can draw on the latest genomic and environmental data and approaches.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David S Cameron, MD 17 Wells St, Ste. 201, Westerly, RI 02891-2923 Ph: (401) 596-2033 | David S Cameron, MD 17 Wells St, Ste. 201, Westerly, RI 02891-2923 Ph: (401) 596-2033 |
News Archive
Virginia Commonwealth University researchers are testing a vaccine against opioid abuse developed by the Scripps Research Institute in California. The vaccine is meant to block the effects of heroin and fentanyl in patients with opioid use disorder.
Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary artery bypass grafting.
The International Committee of Medical Journal Editors (ICMJE) issued a statement today that the 11 member journals will require, as a condition of consideration for publication, registration in a public trials registry for clinical studies involving human patients.
Previous investigations have fallen short of proving cause-effect due to the complexity of human genetics and varying lifestyles. But the EU-funded GABRIEL study has pooled the very best in the field from all over Europe and can draw on the latest genomic and environmental data and approaches.
› Verified 2 days ago
Jeffrey Feldman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 17 Wells St, Ste. 201, Westerly, RI 02891 Phone: 401-596-2033 Fax: 401-596-9294 |